ROYAL BANK OF CANADA - CALUMET SPECIALTY PRODS PTNR ownership

CALUMET SPECIALTY PRODS PTNR's ticker is CLMT and the CUSIP is 131476103. A total of 71 filers reported holding CALUMET SPECIALTY PRODS PTNR in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CALUMET SPECIALTY PRODS PTNR
ValueSharesWeighting
Q3 2023$5,998,000
+21.8%
314,020
+1.1%
0.00%
+100.0%
Q2 2023$4,925,000
-4.6%
310,544
+4.5%
0.00%0.0%
Q1 2023$5,165,000
+28.8%
297,196
+25.1%
0.00%0.0%
Q4 2022$4,010,000
+36.2%
237,583
+3.3%
0.00%0.0%
Q3 2022$2,945,000
+24.1%
229,908
+0.6%
0.00%0.0%
Q2 2022$2,374,000
-22.7%
228,483
+1.2%
0.00%0.0%
Q1 2022$3,073,000
+2.2%
225,802
-0.9%
0.00%0.0%
Q4 2021$3,007,000
+68.2%
227,794
+0.8%
0.00%
Q3 2021$1,788,000
+16.6%
226,053
+1.2%
0.00%
Q2 2021$1,534,000
+19.6%
223,335
+6.2%
0.00%
Q1 2021$1,283,000
+47.8%
210,300
-24.2%
0.00%
Q4 2020$868,000
-4.0%
277,274
-21.8%
0.00%
Q3 2020$904,000
-5.7%
354,561
-15.7%
0.00%
Q2 2020$959,000
+118.9%
420,645
+0.8%
0.00%
Q1 2020$438,000
-74.3%
417,302
-10.5%
0.00%
-100.0%
Q4 2019$1,702,000
+6.7%
466,153
+6.4%
0.00%0.0%
Q3 2019$1,595,000
-20.6%
438,155
-8.6%
0.00%0.0%
Q2 2019$2,008,000
+11.7%
479,259
-5.1%
0.00%0.0%
Q1 2019$1,798,000
+43.7%
505,060
-10.7%
0.00%0.0%
Q4 2018$1,251,000
-66.6%
565,801
-3.4%
0.00%
-50.0%
Q3 2018$3,748,000
-15.8%
585,605
-2.0%
0.00%0.0%
Q2 2018$4,452,000
+4.6%
597,609
-1.0%
0.00%0.0%
Q1 2018$4,255,000
-8.6%
603,582
-0.2%
0.00%0.0%
Q4 2017$4,655,000
+4.6%
604,628
+13.4%
0.00%0.0%
Q3 2017$4,452,000
+116.2%
533,231
+10.1%
0.00%
+100.0%
Q2 2017$2,059,000
+22.1%
484,494
+9.2%
0.00%0.0%
Q1 2017$1,687,000
+56.8%
443,818
+65.1%
0.00%0.0%
Q4 2016$1,076,000
-54.0%
268,875
-48.1%
0.00%0.0%
Q3 2016$2,337,000
-6.3%
518,184
+1.8%
0.00%0.0%
Q2 2016$2,494,000
-67.2%
508,978
-21.4%
0.00%
-80.0%
Q1 2016$7,613,000
-34.9%
647,915
+10.3%
0.01%
-37.5%
Q4 2015$11,696,000
-16.5%
587,373
+1.9%
0.01%
-20.0%
Q3 2015$13,999,000
-5.5%
576,631
-0.9%
0.01%0.0%
Q2 2015$14,815,000
+9.3%
581,907
+3.3%
0.01%
+11.1%
Q1 2015$13,552,000
+46.7%
563,525
+36.7%
0.01%
+50.0%
Q4 2014$9,239,000
-23.0%
412,234
-5.7%
0.01%
-25.0%
Q3 2014$12,002,000
-5.8%
437,228
+9.1%
0.01%
-11.1%
Q2 2014$12,744,000
+17.5%
400,750
-4.5%
0.01%
+12.5%
Q1 2014$10,849,000
+9.2%
419,816
+10.0%
0.01%
+14.3%
Q4 2013$9,933,000
+9.4%
381,760
+14.8%
0.01%0.0%
Q3 2013$9,077,000
+15.9%
332,621
+54.5%
0.01%0.0%
Q2 2013$7,833,000215,3160.01%
Other shareholders
CALUMET SPECIALTY PRODS PTNR shareholders Q3 2023
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 2,249,209$7,040,0007.61%
Adams Asset Advisors, LLC 4,555,224$14,257,0003.90%
KNOTT DAVID M 2,645,000$8,279,0003.75%
Springhouse Capital Management, LP 356,722$1,117,0001.08%
Barnett & Company, Inc. 309,882$969,0000.61%
Windsor Wealth Management, Inc. 206,176$645,0000.16%
Danda Trouve Investment Management, Inc. 17,738$56,0000.07%
O'Brien Greene & Co. Inc 33,001$103,0000.04%
Plancorp, LLC 45,000$141,0000.04%
Accel Wealth Management 10,306$32,0000.03%
View complete list of CALUMET SPECIALTY PRODS PTNR shareholders